The purpose of this memorandum is to notify you that we are initiating the subject evaluation.
The objective of this evaluation is to determine the extent to which the DoD and Military Departments have implemented the FY 2024 National Defense Authorization Act requirements to (1) have naloxone readily available on all military installations and in operational environments, and (2) establish a standardized tracking system for naloxone distribution and personnel’s illegal use of fentanyl. We may revise the objective as the evaluation proceeds, and we will also consider suggestions from management for additional or revised objectives. We plan to perform this evaluation in accordance with the Council of the Inspectors General on Integrity and Efficiency’s “Quality Standards for Inspection and Evaluation.”